Type 1 Diabetes TrialNet (TrialNet) Studies:
TrialNet is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes. Here at CHEO we partake in 3 TrialNet Studies:
1. The Natural History Study: is an international study which screens and observes relatives of people with type 1 diabetes to learn more about who develops diabetes and how.
2. The Oral Insulin Study: is an international study which tests whether a daily oral insulin capsule can prevent or delay the disease in at-risk relatives of people with type 1 diabetes.
3. LIFT Study: is an international study which monitors the progress of children and youth who have developed type 1 diabetes.
MiTy Kids Study:
There is some evidence that children of mothers with type 2 diabetes have a higher than average chance of being overweight or obese as they get older, and having risk factors for heart disease.
MiTy Kids Study is a follow-up study to the MiTy Trial which will determine whether treatment with metformin during pregnancy in women with type 2 diabetes reduces the child’s risk of being overweight or obese, and reduce his/her risk of risk factors for heart disease.
The cause of
type 1 diabetes has been investigated for several decades. Strong evidence
suggests that environmental factors increase the risk of diabetes in people who
are genetically susceptible. If these environmental factors could be identified
and eliminated, it should be possible to decrease the number of children who
develop type 1 diabetes.
TRIGR is an
international study testing whether hydrolyzed infant formula compared to cow's
milk-based formula decreases risk of developing type 1 diabetes in children
with increased genetic susceptibility. This study is no longer recruiting and
the children are currently in the follow-up phase. The study will be completed in 2017.